Neuro Stents & Coils Technology and Market Forecast

The market for Neuro-Endovascular Devices which currently stands at $590 million is expected to reach $1.1 billion by 2012.

The increase in use of non-invasive neuro-imaging modalities in the outpatient setting has led to a sharp increase in the number of truly asymptomatic, intracranial aneurysms being diagnosed.

Continuous improvement in coil design and composition, the introduction of stents for the management of wide-necked cerebral aneurysms and the advancement in guiding catheters and wire designs are improving the utility of coils in intracranial aneurysm repair.

Currently, over 60% of aneurysms are treated with surgical clipping and less than 40% are treated with coils. This ratio is bound to change as coiling becomes more established and the technique more adopted.

Medtech Ventures' Neuro Stents & Coils - Technology & Market Forecast is an exclusive introduction to this rapidly growing market.

The report provides a brief, but through, analysis of this market with profiles of leading participants and forecasts to the year 2012.

With Neuro Stents & Coils - Technology & Market Forecast, you’ll be able to better:

• Identify emerging technologies and the companies behind them
• Leverage your own technology and brain storm new business opportunities
• Assess market size and growth potential for coils, stents and delivery devices
• Understand current market dynamics, competitors positions and market shares
• Assess market potential and have access to forecasts till 2012
• Monitor the competition’s marketed and in-development products
• Investigate mergers, acquisitions and licensing possibilities

Neuro Stents & Coils - Technology & Market Forecast is targeted at busy senior executives in medical technology companies who are interested in developing an understanding of this emerging growth area.

Table of Contents

1. Executive Summary

2. State of the Science

2.1 Cerebral Aneurysm
2.1.1 Epidemiology
2.1.2 Diagnosis
2.1.3 Management
2.2 Aneurysm Clipping
2.3 Aneurysm Coiling
2.4 Balloon Assisted Coiling
2.5 Stent Assisted Coiling
2.6 Liquid Embolics
2.7 Current Trends
2.8 Clinical Trials Update

3. State of the Technology

3.1 Procedure
3.1.1 Aneurysm Coiling
3.1.2 Biomaterial Coated Coils
3.1.3 Intracranial Stenting
3.1.4 Liquid Embolic Agents
3.2 Physicians
3.3 Hospitals

4. Companies & Products

4.1 Balt
4.2 Boston Scientific
4.3 Cardiatis
4.4 Collagen Matrix
4.5 Concentric
4.6 Cook
4.7 Cordis
4.8 EV3
4.9 Medtronic
4.10 MicroVention
4.11 Micrus
4.12 NeuroVasx
4.13 Terumo

5. Market Forecast

5.1 The Opportunity
5.2 Market Potential
5.3 Market Forecast

List of Tables

1. Neuro Endovascular Device Market - Market Revenue & Growth Rates (2002 – 2006)
2. Neuro Endovascular Device Market – Market Forecasts (2007 – 2012)
3. Clinical Trials Updates (2006)
4. Currently Available Biomaterial Coated Coils
5. Currently Available and In-Development Cerebral Stents
6. Companies and Their Products (2006)
7. Neuro Endovascular Device Market – Companies Market Share (2006)
8. Boston Scientific Neuro Endovascular Revenue (2002 – 2006)
9. EV3 / Microtherapeutics Neuro Endovascular Revenue (2002 – 2006)
10. Micrus Neuro Endovascular Revenue (2001 – 2006)
11. Estimated Cost of Treatment of a Cerebral Aneurysm
12. Endovascular Embolization of a Cerebral Aneurysm – Market Potential
13. Neuro Endovascular Global Market Segmented by Device Category (2002 - 2006)
14. Neuro Endovascular Global Market Forecast Segmented by Device Category (2006 - 2012)